ReviewGenomics, proteomics & bioinformatics2026
Approaches to Studying Viral Pangenome Variation Graphs.
Review in Genomics, proteomics & bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A novel Vector-Symbolic Architecture for graph encoding and its application to viral pangenome-based species classification.BioData mining · 2026Article
- Using pangenome variation graphs to improve mutation detection in a large DNA virus.Microbial genomics · 2026Article
- Panalyze: automated virus pangenome variation graph construction, analysis and annotation.Bioinformatics advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Pangenome variation graphs (PVGs) allow for the representation of genetic diversity in a more nuanced way than traditional reference-based approaches. Here, I focus on how PVGs are a powerful tool for studying genetic variation in viruses, offering insights into the complexities of viral quasispecies, mutation rates, and population dynamics. PVGs originated in human genomics and hold great promise for viral genomics. Previous work has been constrained by small sample sizes and gene-centric methods, whereas PVGs enable a more comprehensive approach to studying viral diversity. Large viral genome collections should be used to make PVGs, which offer significant advantages. Here, I outline accessible tools to achieve their construction. These tools span PVG construction, PVG file formats, PVG manipulation and analysis, PVG visualisation, PVG openness measurement, and read mapping to PVGs. Additionally, the development of PVG-specific formats for mutation representation and personalised PVGs that reflect specific research questions will further enhance PVG applications. Challenges remain, particularly in managing nested variants, optimising error detection, optimising k-mer/minimizer-based approaches for AT-rich genomes, incorporating long-read sequencing data, and developing scalable visualisation approaches. Nevertheless, PVGs offer a new opportunity for viral population genomics, and a testing ground for tool development prior to application to larger eukaryotic genomes. These advances will enable more accurate and comprehensive detection of viral mutations, contributing to a deeper understanding of viral evolution and genotype-phenotype associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.